Literature DB >> 7812737

Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.

C Baudeau1, F Delarue, C J Hé, G Nguyen, C Adida, M N Peraldi, J D Sraer, E Rondeau.   

Abstract

MHC class II-encoded molecules HLA-DR, -DP and -DQ play a pivotal role in the human immune response. Their constitutive expression is restricted to a number of immunocompetent cells referred to as antigen-presenting cells. However, gamma-interferon (gamma-IFN) has been shown to induce MHC class II molecule expression in several epithelia. Using flow cytometric analysis, we show here that normal and SV40-transformed human podocytes in culture constitutively expressed gamma-IFN receptors. We also show that MHC class I molecules are constitutively expressed in these cells and that HLA-DR, -DP and -DQ expression, which is not found in unstimulated cells, can be induced by gamma-IFN stimulation. This induction was a time-dependent event, a lag phase of 24-48 h being necessary for MHC class II molecules to become detectable at the cell surface by flow cytometric analysis. Induction of MHC class II molecules in human podocytes also showed a concentration dependence, a plateau being reached at a concentration of 500 IU of gamma-IFN/ml of culture medium. This effect was blunted by coincubation of the cells with an antihuman gamma-IFN receptor monoclonal antibody. HLA-DR expression was associated with specific mRNA accumulation, as detected by Northern blot analysis. By indirect immunofluorescence, the intercellular adhesion molecule 1 was also induced by gamma-IFN stimulation. Induction of DR, DP and DQ in human podocytes may be involved in the pathogenesis of immune glomerulonephritis in man.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812737

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  8 in total

1.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

3.  B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.

Authors:  Alfred Hj Kim; Jun-Jae Chung; Shreeram Akilesh; Ania Koziell; Sanjay Jain; Jeffrey B Hodgin; Mark J Miller; Thaddeus S Stappenbeck; Jeffrey H Miner; Andrey S Shaw
Journal:  JCI Insight       Date:  2017-11-02

4.  Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.

Authors:  Steven D Crowley; Campbell W Frey; Samantha K Gould; Robert Griffiths; Phillip Ruiz; James L Burchette; David N Howell; Natalia Makhanova; Ming Yan; Hyung-Suk Kim; Pierre-Louis Tharaux; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21

Review 5.  Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.

Authors:  Simanta Pathak; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-30       Impact factor: 5.156

6.  Defining the molecular character of the developing and adult kidney podocyte.

Authors:  Eric W Brunskill; Kylie Georgas; Bree Rumballe; Melissa H Little; S Steven Potter
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

7.  Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Federica Portale; Paolo Tentorio; Xiqian Lan; Moin A Saleem; Karl Skorecki; Pravin C Singhal; Domenico Mavilio
Journal:  Retrovirology       Date:  2016-09-06       Impact factor: 4.602

8.  HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.

Authors:  Jiqiu Wen; Kenan Xie; Mingchao Zhang; Jinsong Chen; Jiong Zhang; Dongrui Cheng; Xue Li; Shuming Ji; Zhihong Liu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.